Nanoparticle-based anti-VEGF treatment for Ocular Neovascularization [ 2013 - 2016 ]

Research Grant

Researchers: Dr Hong Zhang (Principal investigator) ,  A/Pr James Bourne ,  Dr Hsin-Hui Shen ,  Prof Gregory Dusting ,  Prof Keith Mclean

Brief description Diseases like AMD and DR are the leading cause for substantial and irreversible vision loss as a direct effect of pathologic ocular neovascularization and have a significant economic impact on individuals, families, health systems and countries. Nowadays, the treatment requires frequent intravitreal injections of anti-VEGF antibody with all the risks of an invasive intraocular procedure. Nanotechonoly-based drug delivery system will provide a less invasive treatment for this kind of disease.

Funding Amount $AUD 576,921.73

Funding Scheme Project Grants

Notes Standard Project Grant